Södertälje, Sweden

Martin Nylöf

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 6.7

ph-index = 4

Forward Citations = 37(Granted Patents)


Location History:

  • Södertälje, SE (2006 - 2013)
  • Sodertalje, SE (1996 - 2019)

Company Filing History:


Years Active: 1996-2019

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Martin Nylöf: Innovator in Pharmaceutical Compounds

Introduction

Martin Nylöf is a distinguished inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various cognitive impairments and related pathologies. With a total of seven patents to his name, Nylöf's work is recognized for its potential impact on treating serious health conditions.

Latest Patents

Nylöf's latest patents include innovative compounds and their applications as BACE inhibitors. These compounds are designed to address Aβ-related pathologies, including Down's syndrome and Alzheimer's disease. His research focuses on therapeutic methods for the treatment and prevention of cognitive impairments, such as mild cognitive impairment and memory loss. Another notable patent involves N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives, which are aimed at pain management. This invention encompasses new compounds, pharmaceutical compositions, and processes for their preparation.

Career Highlights

Throughout his career, Martin Nylöf has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Nylöf has collaborated with notable colleagues such as Stefan Berg and Yevgeni Besidski. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.

Conclusion

Martin Nylöf's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in addressing critical health challenges. His work continues to pave the way for advancements in treatment options for cognitive impairments and related disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…